SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001457612-19-000080
Filing Date
2019-05-21
Accepted
2019-05-21 08:01:39
Documents
5
Period of Report
2019-05-21
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a052120198-k.htm 8-K 40583
2 EXHIBIT 3.1 degenoceaamendment.htm EX-3.1 2243
3 degenoceaamendment001.jpg GRAPHIC 87044
4 degenoceaamendment002.jpg GRAPHIC 187421
5 degenoceaamendment003.jpg GRAPHIC 40706
  Complete submission text file 0001457612-19-000080.txt   478482
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 19840829
SIC: 2836 Biological Products, (No Diagnostic Substances)